Inovio Pharmaceuticals
INO
#7923
Rank
โ‚น14.85 B
Marketcap
โ‚น572.16
Share price
0.74%
Change (1 day)
43.12%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2024 (TTM): โ‚น49.25 M

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM) is โ‚น49.65 M. In 2023 the company made a revenue of โ‚น69.26 M a decrease over the revenue in the year 2022 that were of โ‚น0.84 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น49.25 M-28.89%
2023 โ‚น69.26 M-91.84%
2022 โ‚น0.84 B542.07%
2021 โ‚น0.13 B-75.56%
2020 โ‚น0.54 B84.87%
2019 โ‚น0.29 B-86.2%
2018 โ‚น2.12 B-21.35%
2017 โ‚น2.69 B12.16%
2016 โ‚น2.40 B-10.85%
2015 โ‚น2.69 B307.38%
2014 โ‚น0.66 B-20.49%
2013 โ‚น0.83 B269.02%
2012 โ‚น0.22 B-56.47%
2011 โ‚น0.51 B88.1%
2010 โ‚น0.27 B-35.16%
2009 โ‚น0.42 B307.39%
2008 โ‚น0.10 B-44.99%
2007 โ‚น0.18 B23.42%
2006 โ‚น0.15 B-37.57%
2005 โ‚น0.24 B435.98%
2004 โ‚น45.9 M1149.6%
2003 โ‚น3.67 M-59.58%
2002 โ‚น9.08 M
2000 โ‚น0.25 B-32.09%
1999 โ‚น0.38 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น4.668 T 9,401,125.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.263 T 14,627,708.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.64 B 3,219.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.099 T 8,255,244.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น5.241 T 10,556,299.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.311 T 6,668,194.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น2.332 T 4,697,471.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น53 M 6.76%๐Ÿ‡บ๐Ÿ‡ธ USA